...
首页> 外文期刊>Journal of experimental & clinical cancer research : >PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer
【24h】

PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer

机译:RNA结合蛋白RBM38通过增强其在乳腺癌中的mRNA稳定性来上调PTEN表达

获取原文
   

获取外文期刊封面封底 >>

       

摘要

PTEN (phosphatase and tensin homolog gene on chromosome 10), a well-characterized tumor suppressor, is a key regulator of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway involved in cell survival, metastasis and cell renewal. PTEN expression is closely related to the phenotype, prognosis and drug selection in breast cancer. It is mainly regulated by transcriptional and post-transcriptional modifications. RNA binding motif protein 38 (RBM38), an RNA-binding protein (RBP) and a target of P53 family, plays a crucial role in the regulation of cellular processing, especially in post-transcription regulation and gene transcription. In this study, we investigated a new post-transcription regulation mechanism of PTEN expression by RBM38 in breast cancer. Immunohistochemistry, lentivirus transfections, Western blotting analysis, qRT-PCR and ELISA were used to conduct the relation between RBM38 and PTEN. RNA immunoprecipitation, RNA electrophoretic mobility shift and dual-luciferase reporter assays were employed to identify the direct binding sites of RBM38 with PTEN transcript. Colony formation assay was conducted to confirm the function of PTEN in RBM38-induced growth suppression. PTEN expression was positively associated with the expression of RBM38 in breast cancer tissues and breast cancer cells. Moreover, RBM38 stabilized PTEN transcript to enhance PTEN expression via binding to multiple AU/U- rich elements (AREs) in 3′-untranslated region (3′-UTR) of PTEN transcript. Additionally, specific inhibitors of PTEN activity and small interfering (siRNA) of PTEN expression inhibited RBM38-mediated suppression of proliferation, which implied that RBM38 acted as a tumor suppressor partly by enhancing PTEN expression. The present study revealed a new PTEN regulating mechanism that PTEN was positively regulated by RBM38 via stabilizing its transcript stability, which in turn alleviated RBM38-mediated growth suppression.
机译:PTEN(第10号染色体上的磷酸酶和张力蛋白同源基因)是一个特征明确的肿瘤抑制因子,是参与细胞存活,转移和细胞更新的磷脂酰肌醇3-激酶(PI3K)/ AKT通路的关键调节剂。 PTEN表达与乳腺癌的表型,预后和药物选择密切相关。它主要受转录和转录后修饰的调控。 RNA结合基序蛋白38(RBM38)是一种RNA结合蛋白(RBP),是P53家族的靶标,在调节细胞加工过程中,尤其是在转录后调节和基因转录中起着至关重要的作用。在这项研究中,我们调查了RBM38在乳腺癌中PTEN表达的新转录后调控机制。免疫组化,慢病毒转染,Western印迹分析,qRT-PCR和ELISA进行了RBM38和PTEN之间的关系。 RNA免疫沉淀,RNA电泳迁移率变化和双荧光素酶报告基因测定被用来鉴定RTEN38与PTEN转录本的直接结合位点。进行菌落形成测定以证实PTEN在RBM38诱导的生长抑制中的功能。 PTEN表达与乳腺癌组织和乳腺癌细胞中RBM38的表达正相关。此外,RBM38通过结合PTEN转录物的3'-非翻译区(3'-UTR)中的多个富含AU / U的元件(ARE)来稳定PTEN转录物,从而增强PTEN的表达。此外,PTEN活性的特异性抑制剂和PTEN表达的小干扰(siRNA)抑制了RBM38介导的增殖抑制,这暗示RBM38部分地通过增强PTEN表达来充当肿瘤抑制因子。本研究揭示了一种新的PTEN调控机制,即PTEN通过稳定其转录本稳定性而受到RBM38的正调控,从而减轻了RBM38介导的生长抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号